Interestingly, gene deletion or pharmacological blockade of astrocytic KCa3.1 reduce ER stress and prevent downstream neuronal loss in APP/PS1 mice [58], thus highlighting the importance of the astrocytic component in neuronal fate during AD progression. This evidence concerns the gene APP and Alzheimer disease.